Skip to content
10-Q

Quarterly Report

Zander Therapeutics, Inc

0001607062-19-000249

← back to feed
Filed
May 31, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · May 20, 2019 6.79M sh
Operating Cash Flow Q3 2019 · Mar 31, 2019 −$1.01M
Operating Cash Flow Q3 2019 · Mar 31, 2018 −$714.1K
Cash And Equivalents Q3 2019 · Mar 31, 2019 $270.23K
Cash And Equivalents Q3 2019 · Jun 30, 2018 $370.31K
Cash And Equivalents Q3 2019 · Mar 31, 2018 $674.26K
Cash And Equivalents Q3 2019 · Jun 30, 2017 $96.01K
Stockholders Equity Q3 2019 · Mar 31, 2019 −$1.1M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$948.31K
Stockholders Equity Q3 2019 · Sep 30, 2018 −$597.83K
Stockholders Equity Q3 2019 · Jun 30, 2018 −$627.36K
Stockholders Equity Q3 2019 · Mar 31, 2018 $739.04K
Stockholders Equity Q3 2019 · Dec 31, 2017 $608.99K
Stockholders Equity Q3 2019 · Sep 30, 2017 −$182.63K
Stockholders Equity Q3 2019 · Jun 30, 2017 −$131.24K
Current Liabilities Q3 2019 · Mar 31, 2019 $1.84M
Current Liabilities Q3 2019 · Jun 30, 2018 $1.1M
Total Liabilities Q3 2019 · Mar 31, 2019 $1.84M
Total Liabilities Q3 2019 · Jun 30, 2018 $1.1M
Current Assets Q3 2019 · Mar 31, 2019 $384.95K
Current Assets Q3 2019 · Jun 30, 2018 $472.2K
Total Assets Q3 2019 · Mar 31, 2019 $747.2K
Total Assets Q3 2019 · Jun 30, 2018 $472.2K
Sga Expense Q3 2019 · Mar 31, 2019 $307.36K
Sga Expense Q3 2019 · Mar 31, 2019 $667.55K
Sga Expense Q3 2019 · Mar 31, 2018 $19.99K
Sga Expense Q3 2019 · Mar 31, 2018 $62.13K
Rd Expense Q3 2019 · Mar 31, 2019 $38.4K
Rd Expense Q3 2019 · Mar 31, 2019 $533.05K
Rd Expense Q3 2019 · Mar 31, 2018 $311.82K
Rd Expense Q3 2019 · Mar 31, 2018 $366.82K
Net Income Q3 2019 · Mar 31, 2019 −$419.33K
Net Income Q3 2019 · Mar 31, 2019 −$1.54M
Net Income Q3 2019 · Dec 31, 2018 −$350.48K
Net Income Q3 2019 · Sep 30, 2018 −$784.6K
Net Income Q3 2019 · Mar 31, 2018 −$397.29K
Net Income Q3 2019 · Mar 31, 2018 −$691.16K
Net Income Q3 2019 · Dec 31, 2017 −$166.64K
Net Income Q3 2019 · Sep 30, 2017 −$127.23K
Operating Income Q3 2019 · Mar 31, 2019 −$420K
Operating Income Q3 2019 · Mar 31, 2019 −$1.54M
Operating Income Q3 2019 · Mar 31, 2018 −$396.16K
Operating Income Q3 2019 · Mar 31, 2018 −$681.32K